Liver B Cells Promotes MASLD Progression via the Apelin/APLNR System
Authors:
Open Access
- 1 January 2025
- journal article
- research article
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 22 (1) , 197-208
Abstract
Aims: Investigate the role of the apelin/APLNR axis in metabolic dysfunction-associated steatotic liver disease (MASLD), focusing on the progression from metabolic dysfunction-associated simple steatotic liver (MASS) to metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis, with emphasis on liver B cells.Keywords
This publication has 39 references indexed in Scilit:
- Apelin inhibits adipogenesis and lipolysis through distinct molecular pathwaysMolecular and Cellular Endocrinology, 2012
- Enhanced expressions of apelin on proliferative hepatic arterial capillaries in human cirrhotic liverHepatology Research, 2012
- Prevention of Fibrosis Progression in CCl4-Treated Rats: Role of the Hepatic Endocannabinoid and Apelin SystemsThe Journal of Pharmacology and Experimental Therapeutics, 2012
- Apelin Mediates the Induction of Profibrogenic Genes in Human Hepatic Stellate CellsEndocrinology, 2010
- The apelin–APJ system in heart failureBiochemical Pharmacology, 2008
- Apelin-13 induces ERK1/2 but not p38 MAPK activation through coupling of the human apelin receptor to the Gi2 pathwayActa Biochimica et Biophysica Sinica, 2008
- Mechanism of rapid-phase insulin response to elevation of portal glucose concentrationAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- A human hepatocellular in vitro model to investigate steatosisChemico-Biological Interactions, 2007
- Raji revisited: cytogenetics of the original Burkitt's lymphoma cell lineLeukemia, 2004
- The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanismRegulatory Peptides, 2001